Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 10 June 2014 on appointing a member of the Committee for Orphan Medicinal Products (Text with EEA relevance)

Rozhodnutie č. 611/2014

Text language

Important dates

Declared: 10. júna 2014
Approved: 10. júna 2014
Effective from: 1. júla 2014
Effective until: 1. septembra 2017

Documents and links

COMMISSION DECISION

of 10 June 2014

on appointing a member of the Committee for Orphan Medicinal Products

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,

Having regard to the recommendation of the European Medicines Agency of 14 March 2014,

Whereas:

(1)

The term of office of one member of the Committee for Orphan Medicinal Products, hereinafter ‘the Committee’, set up in accordance with Article 4 of Regulation (EC) No 141/2000, expires on 31 August 2014. It is necessary, therefore, to appoint one member to the Committee.

(2)

The European Medicines Agency has recommended one person for nomination.

(3)

The member of the Committee should be appointed for a period of three years starting on 1 September 2014,

HAS DECIDED AS FOLLOWS:

Sole Article

On the recommendation of the European Medicines Agency, the following is hereby appointed member of the Committee for a term of three years, from 1 September 2014:

Prof. Bruno SEPODES

Done at Brussels, 10 June 2014.

For the Commission

On behalf of the President

Tonio BORG

Member of the Commission

Poznámky